Molecular Partners AG: Full-year 2017 Results of Molecular Partners AG Dienstag, 30. Januar 2018 - 10:02
| Invitation (PDF) | ||||||||||||||
| ||||||||||||||
Thursday, February 08, 2018, 2:00pm (CET) –
Dear Sir/Madam
Molecular Partners AG cordially invites you to participate in the presentation of the company's preliminary unaudited key financials for FY 2017 as well as a corporate update which will take place as follows:
Please indicate if you would like to attend the presentation by completing and returning the registration form by Monday, February 05, 2018.
The presentation and the press release will be available on www.molecularpartners.com from 7:00am (CET) on Thursday, February 08, 2018. The full audited Annual Report 2017 of the company is expected to be published on March 16, 2018.
Best regards,
Please dial-in approximately 10 minutes before the start of the presentation in order to register. Participants will have the opportunity to ask questions after the presentation.
To follow the audio webcast of the FY17 results presentation: | ||||||||||||||
About Molecular Partners AG Molecular Partners AG is a clinical-stage biopharmaceutical company that is developing a new class of therapies known as DARPin® therapies. With a management team that includes many of the founding scientists, the company continues to attract talented individuals who share the passion to develop breakthrough medicines for serious diseases. Molecular Partners has compounds in various stages of clinical and preclinical development and several more in the research stage, with a current focus on ophthalmology and oncology. The company establishes research and development partnerships with leading pharmaceutical companies and is backed by established biotech investors.
For more information regarding Molecular Partners AG, go to: www.molecularpartners.com. |
